Behrang Mazahery, MD
Orthopaedic Surgery · Reston, VANPI 1225051295
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 97.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $21,011 and has fallen 98.4% since, to $326 in 2025.
Across 92 payments — averaging $383.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$34K
- Globus Medical$322
- Spine Wave, Inc.$224
- Nevro Corp.$191
- Baxter Healthcare$131
- Abbott$37
- plus $82 from 5 others
What the payments were for
- Consulting fees$19,17554%
- Speaking & faculty fees$10,40029%
- Travel & lodging$3,0719%
- Food & beverage$2,6588%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 73 | $34,318 |
| Globus Medical(2 entities) | 6 | $322 |
| Spine Wave, Inc. | 4 | $224 |
| Nevro Corp. | 2 | $191 |
| Baxter Healthcare | 1 | $131 |
| Abbott | 1 | $37 |
| Alphatec Spine, Inc | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLYDESDALE$11,357
- Mazor X Stealth Edition$7,384
- UNID_PASS$6,002
- MazorX - Renaissance$5,656
- Senza$145
- TISSEEL$131
- STEALTHSTATION S8 PLATFORM$119
- INTELLIS ADAPTIVESTIM$112
- SPINAL IMPLANT$104
How this compares
$35,303 in reported general payments places this provider in the 85th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 173 | $1,135 |
| Diclofenac Sodium | 114 | $1,129 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 12 | $732 |
| Gabapentin | 21 | $252 |
| Tramadol Hcl | 57 | $180 |
| Oxycodone Hcl | 17 | $80 |
| Cyclobenzaprine Hcl | 18 | $72 |
| Meloxicam | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Reston
- James ReevesReston$159K
- George AguiarReston$127K
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.